Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
Comparative Studies on Two Active Enzyme Forms of Human Urinary Urokinase. I. Purification by Serial Column Chromatography and Homogeneity Analyses of Molecular Weight and Isoelectric Point
NOBUHIKO MIWAHIROICHI TAKAYANAGIAKIRA SUZUKI
Author information
JOURNALS FREE ACCESS

Volume 29 (1981) Issue 2 Pages 463-471

Details
Download PDF (1094K) Contact us
Abstract

A method for the efficient further purification of two active forms of urokinase (UK) [EC. 3. 4. 21. 31] from partially purified human urinary UK was established by serial column chromatography on Sephadex G-100, Sephadex G-75, and SP-Sephadex C-50. According to Ferguson plots two active forms showed molecular weights of 5.5×104 (H-UK) and 3.6×104 (H-UK). Both UK forms were shown to be homogeneous by SDS-polyacrylamide gel electrophoresis, gel gradient electrophoresis, and Ouchterlony's double immunodiffusion method. Amino acid analysis showed that there was no marked difference in composition between H- and L-UK. The specific activity of H-UK was 1.2×105 IU/mg protein, which exceeds the highest specific activity that has ever been obtained by other investigators, and that of L-UK was 1.52×105 IU/mg protein. These results suggest that this serial column chromatography procedure is effective for the purification of H-UK, which is known to be a pharmacologically advantageous form. As judged by isotachoelectrophoresis, H-UK contained five subforms with pI values of 8.7, 8.9, 9.1, 9.2, and 9.4, and L-UK contained the same number of subforms with pI values of 7.5, 8.3, 8.8, 9.4 and 9.7. The pI values of the subforms with the highest specific activity were 9.4 for H-UK and 8.3 and 8.8 for L-UK. Judging from the dissimilarity in the pI values of UK preparations obtained so far by other investigators and ourselves, we consider that the subforms of UK obtained after purification do not correspond to the forms present in vivo, but are artifacts of the purification procedures used.

Information related to the author
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top